Search Results - R. Rozzini
- Showing 1 - 1 results of 1
-
1
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19 by B. Cosmi, M. Giannella, G. Fornaro, F. Cristini, A. Patacca, A. Castagna, F. Mazzaferri, S. Testa, A. Pan, M. Lupi, P. Brambilla, A. Montineri, S. Frattima, E. G. Bignami, M. Salvetti, G. De Stefano, E. Grandone, G. Di Perri, R. Rozzini, A. Stella, A. Romagnoli, F. Drago, P. Viale
Published in BMC Infectious Diseases (2023-10-01)Get full text
Article
